| Name | Title | Contact Details |
|---|
NYC Health + Hospitals is the nation`s largest public health care delivery system. We are an integrated network of hospitals, trauma centers, neighborhood health centers, nursing homes, and post-acute care centers. We are a home care agency and a health plan, MetroPlus. The health system provides essential services to more than 1.4 million New Yorkers every year in more than 70 patient care locations and in their homes. Our talented workforce of more than 40,000 represents the diversity of our city and the communities we serve. The excellence of our staff, and our continued mission to care for all without exception, make us unique and rightly positioned to provide equitable, high-quality, culturally responsive, and affordable health care in every New York City community. Our promise to New Yorkers: Empower every New Yorker – without exception – to live the healthiest life possible by providing equitable, high quality, culturally responsive, and affordable health care in every community.
MSPCA is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Jamaica Plain, MA. To find more information about MSPCA, please visit www.mspca.org
In 1972 HOPE, Inc and ARC Children`s Program consolidated into one single service organization. In 1976 this organization became Sunflower Diversified Services. And now each year, this organization serves over 125 adults, 36 to 42 Pre-school age children and 120 to 140 infants from birth to 3 years old.
Canadian Mental Health Association - Winnipeg Region is a Winnipeg, MB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Unlike traditional approaches that only address symptoms, Cardionomic addresses the conditions root cause of reduced contractility. The therapy uses neuromodulation to benignly increase contractility, thus improving cardiac output therefore increasing renal flow and end organ perfusion. Benignly increasing contractility decreases negative hormonal signaling, and improves in-hospital morbidity/mortality. This breakthrough therapy is also expected to increase pharmacological tolerance at discharge, which will reduce costly readmission and extend life. Spun off from Denali Medical II, a New Enterprise Associates (NEA) backed incubator, Cardionomic is funded by NEA, Greatbatch Medical and Cleveland Clinic Foundation.